SCHEMBL18909448

SCHEMBL18909448

CCC(=O)N1CCC(CN2CCN(C(=O)CN(C)C)CC2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA2D1 P54289 2/20 0.43
CACNA1B Q00975 2/20 0.43
CACNB1 Q02641 2/20 0.43
CACNA1C Q13936 1/20 0.43
EPHX2 P34913 3/20 0.40
HSD11B1 P28845 1/20 0.39
EPHX1 P07099 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
BDKRB1 P46663 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ITGB3 P05106 1/20 0.38
ITGA2B P08514 1/20 0.38
SIGMAR1 Q99720 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAPT P10636 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21281099 0.87 CACNA2D1 (0.42) CACNA2D1CACNA1BCACNB1CACNA1CHSD11B1
SCHEMBL20471042 0.85 HRH3 (0.48) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2
SCHEMBL18909449 0.84 CACNA2D1 (0.45) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2
SCHEMBL22030918 0.84 KDM4E (0.55) CACNA2D1CACNA1BCACNB1CACNA1CALDH1A1
SCHEMBL24521471 0.83 HSD11B1 (0.47) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2
SCHEMBL25701777 0.83 HSD11B1 (0.53) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2
SCHEMBL18909219 0.82 ALDH1A1 (0.52) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2
SCHEMBL12507042 0.82 MAPT (0.49) EPHX2SMN1; SMN2MAPTLMNA
SCHEMBL18909253 0.81 ALDH1A1 (0.55) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2
SCHEMBL18909455 0.81 PKM (0.43) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3596072-B1 PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-06-22 EP disclosed
EP-3416967-B1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-02-09 EP disclosed
EP-3380474-B1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF HOFFMANN LA ROCHE (CH) 2019-08-21 EP disclosed
WO-2017140825-A1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-08-24 WO disclosed
WO-2017089390-A1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-06-01 WO disclosed